Advertisement

Supply Chain Report

8 latest FDA approvals | What are US businesses’ most pressing supply chain concerns? | NLRB issues labor complaint against CHS | Allergan pays $250M for licensing rights to AstraZeneca’s experimental treatment From: Becker's Supply Chain Report <editorial@beckershealthcare.com> Subject: 8…

Mylan apparently underreported EpiPen profits by 60% at Congressional hearing | Wal-Mart considering up to $1B investment in online retailer Flipkart | RN average hourly wage & salary for all 50 states | Supply chain tip of the week: Organizing…

Blackstone buys $1.5B worth of logistics centers | Ohio police race through anti-overdose drug supply | Apollo Global reportedly in talks to acquire CHS’ assets | Mylan CEO says company could have anticipated consumer concern over price hike From: Becker's…

Advertisement

Supply chain salaries to increase nearly 3% in 2017 | Ice maker, sinks linked to UW Medical Center Legionnaires’ outbreak | Weighing the cost of care: How hospitals accommodate obese patients | Mylan CEO to explain EpiPen prices at Sept.…

Mayo’s head of supply chain names a problematic underinvestment | Indiana Blood Center pleads for O-negative donations | Dartmouth-Hitchcock to lay off up to 460 | 4 quotes from supply chain leaders on improving physician engagement From: Becker's Supply Chain…

EpiPen prescriptions spike despite controversy | What’s in Allegan’s new social contract? | A scary twist on opioids: 6 things to know about carfentanil | 110 physician leaders to know From: Becker's Supply Chain Report <editorial@beckershealthcare.com> Subject: EpiPen prescriptions spike…

Nestlé to acquire medical device company Phagenesis | Electrical fire forces Fla. hospital to evacuate 209 patients | Study: Pricey drug-coated stents don’t outperform conventional versions | 4 latest FDA approvals From: Becker's Supply Chain Report <editorial@beckershealthcare.com> Subject: Nestlé to…

Advertisement